Aristeidis Katsanos
PHRI Investigator Aristeidis Katsanos, a member of our stroke and brain health research program, has been given a Young Investigator Award from the 8th European Stroke Organisation Conference (ESOC 2022) just held in Lyon, France.
He was one of seven young investigators bestowed the honour; they were all authors who presented abstracts at the conference, early career researchers, aged 35 or under. They each were rewarded 1000 Euros.
Katsanos was awarded for his abstract, “Intravenous Thrombolysis with Tenecteplase versus Alteplase in Acute Ischemic Stroke Patients within 4.5 Hours from Symptom Onset: A Propensity Score-Matched Analysis from the SITS-ISTR Registry,” which he presented from the podium during ESOC.
The award was handed out May 6, the last day of the conference during the closing ceremony and the large clinical trials session.
Katasanos was also recently elected a member of the ESO Guidelines Board Committee, which actively works in establishing new guidelines in acute stroke care, secondary stroke prevention and rehabilitation.
Earlier this year, he was the first graduate from McMaster University’s stroke fellowship training program to become a Fellow of the Canadian Stroke Consortium (CSC).
Katsanos is an Assistant Professor in the Division of Neurology, Department of Medicine (Neurology) at McMaster, and a neurologist at Hamilton Health Sciences (HHS), as well as an Investigator at PHRI.
A week after his ESOC 22 award, Katsanos received the E.J. Moran Campbell Internal Career Research Award from McMaster’s Department of Medicine.
